Health Care/Hospital
Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine
* Contributing to society and patients through the utilization of iPSC technology developed inJapan * New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application of iPSC-based medicine KYOTO, Japan, Aug. 10, 2...
Cigna Launches World's First Voice-Activated Stress Test
* 'Cigna StressWaves Test' powered by Ellipsis Health's advanced AI technology * First and only stress analysis model to detect both acoustic and semantic patterns in voice * Available free-of-charge with visual stress results in 90-seconds HONG KONG, Aug. 10, 2021 /PRNewswire/ -- Cigna Intern...
Prenetics and New World Development Launch Circle HealthPod, the World's Most Advanced At-Home Covid-19 test
* Circle HealthPod is a Rapid Detection System for all infectious diseases, starting with Covid-19 and will include Flu and STDs in the future * Technology developed at University of Oxford, with PCR quality results in 20 minutes * Circle HealthPod, having received CE-IVD marking, is a reusa...
IMG Appoints Steve Paraboschi as Chief Executive Officer
INDIANAPOLIS, Aug. 10, 2021 /PRNewswire/ -- International Medical Group® (IMG®), an industry-leading international medical insurance, global assistance, and travel insurance company, is pleased to announce that Steve Paraboschi has been appointed as Chief Executive Officer, effective immediately...
Australia's Cancer Organisations Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster' During Pandemic
'New Normal, Same Cancer: Conversations' warns people to get unusual and persistent symptoms checked by their doctor now, to increase detection and improve survival chances, following a slump in cancer testing and screening during the COVID-19 pandemic. * Growing concern among Australian cance...
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation between Arvinas' and Insilico Medicine's scientists on novel PR...
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand
BEIJING, Aug. 9, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority ("MEDSAFE"), which ...
Life Sciences' Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users
The US digital therapeutics market is estimated to witness more than three-and-a-half-fold growth reaching$4.54 billion by 2025, at a CAGR of 29.8%, finds Frost & Sullivan SANTA CLARA, Calif., Aug. 9, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that digital therapeutics (DTx) i...
Thailand's Jan-June Investment Applications Reach USD12 billion, as FDI Quadruple, E&E and Medical Sectors Continue to Expand, BOI says
BANGKOK, Aug. 9, 2021 /PRNewswire/ -- In the first six months of 2021, Thailand's investment applications increased 14% from the year earlier period in terms of the number of projects, and 158% in combined value, led by increasing foreign direct investment (FDI) applications, sustained growth in ...
Antengene and MindRank AI Enter into Collaboration to Advance the Development of Difficult-to-Drug Molecular Targets
SHANGHAI and HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
HANGZHOU and SHAOXING, China, Aug. 9, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase II clinical trial application of ASC40 for the treatment of patients with moderate to severe acne. T...
Innovent Announces the Establishment of the Scientific Advisory Board
SAN FRANCISCO and SUZHOU, China, Aug. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
Endurance Longevity Announces Positive Profit Alert for Interim Results 2021 and Other Exciting Business Updates
HONG KONG, Aug. 6, 2021 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce a positive profit alert for the interim results 2021 for the six month period ended30 June 2021. The ...
AI and Big Data Join Hands to Assist Physicians in Diagnosis and Reporting
TAIPEI, Aug. 6, 2021 /PRNewswire/ -- With the advent of the 5G era and the growing popularity of big data and artificial intelligence applications, the Joint Commission ofTaiwan (JCT) is hosting Smart Healthcare Expo Taipei 2021: International Smart Healthcare Forum (Session 2) with a focus on tw...
Taiwan's medical device company challenges the limit of science, launching the most expensive collagen in the contemporary market
TAIPEI, Aug. 6, 2021 /PRNewswire/ -- As consumers around the world increase their awareness of using beauty and health products, collagen products have become the most popular item. Various manufacturers continue to innovate in accordance with consumer demand. According to Research and Markets, w...
ORI Capital's Portfolio Company Pillar Receives FDA Premarket Approval for its oncoReveal(TM) Dx Lung and Colon Cancer Test
HONG KONG, Aug. 6, 2021 /PRNewswire/ -- ORI Capital, a quantamental healthcare fund manager focused on investing in disruptive healthcare companies globally, announced today the U.S. Food and Drug Administration (FDA) has given its portfolio company, Pillar Biosciences Inc. ("Pillar"), Premarket ...
SURGLASSES' SPINE NAVIGATION SYSTEM CADUCEUS S - An innovation greatly influencing minimally invasive surgeries
TAICHUNG, Aug. 6, 2021 /PRNewswire/ -- Taiwan Main Orthopaedic Biotechnology Co. Ltd (SURGLASSES),Taiwan, a company striving to bring a difference into the real time surgical procedure after the introduction of the first AR assisted Head Mounted Display Foresee-X, is now coming up with a new prod...
Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology
SAN FRANCISCO and SUZHOU, China, Aug. 6, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination
* Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series * Six-fold increase in cross-reactive functional antibodies to Delta variant compared to primary vaccination series * Analysis of sera from primary ...
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine
- Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General ofIndia and to regulatory agencies in Indonesia and Philippines for Novavax' recombinant nanoparticle COVID-19 vaccine - Filing for World Health Organization Emergency Use Listing expected in Augus...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24